MediSpectra Inc.
MediSpectra Inc. of Lexington, Mass.,
has received FDA approval for the Luma cervical imaging system. When used in conjunction
with colposcopy — for women who have had abnormal Pap test results —
the noncontact optical imaging device is expected to improve the detection of high-grade
cervical cancer precursors. A 12-s scan combines fluorescence spectroscopy, white-light
diffuse reflectance spectroscopy and video imaging to provide results during the
examination.
LATEST NEWS
- Method Measures Trapped Qubits While Keeping Others Safe, Close
Sep 26, 2024
- Industrial Laser-Driven Neutron Source Developed for Nondestructive Assessment of Nuclear Waste
Sep 26, 2024
- Glass-Based PICs Developer Expands Following NATO-Supported Funding
Sep 25, 2024
- InZiv Appoints Vice President of R&D: People in the News: 9/25/24
Sep 25, 2024
- Ansys, TSMC, Collaborate with Microsoft on High-Speed Optical Data Transfer
Sep 25, 2024
- Collaboration, Tech Advancement Take Center Stage at Neuroscience 2024
Sep 24, 2024
- HyperLight Lands $37M to Advance Lithium Niobate Tech
Sep 24, 2024
- Integrated Photonics Companies Join Forces, Target Hybrid Solutions Supply Chain
Sep 24, 2024